Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarizotan in Rett syndrome with respiratory symptoms
2015-004448-20Phase 2Terminated
- Sponsor
- Newron Pharmaceuticals
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Rett syndrome (RTT) comparing Sarizotan with Placebo (2 arms). Primary endpoint: Percent reduction in apnea episodes. Started Sep 2016; status: terminated.
02
Drugs
sarizotan
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on 2015-004448-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004448-20.